News from IVAC

December 2018

Beating the world’s deadliest disease against all odds

When it comes to stopping childhood pneumonia, the odds are stacked against the poor and vulnerable; but vaccines can give them a fighting chance. In 2009, approximately 3,400 children died of pneumonia every day. Now, with investments in pneumonia prevention and treatment – including the introduction and scale up of two vaccines to prevent the most common causes of pneumonia death, Haemophilus influenzae type b and pneumococcus – that number has fallen to 1,000.

Read More >
October 2018

Commentary: Pneumonia, Diarrhea, and Measles force Bangladeshi households to make difficult financial decisions when illnesses arise

Few diseases have as much power to cause wide-ranging impact among the population as pneumonia, diarrhea, and measles. These three illnesses can cause long-term disability and can require a significant amount of care. In addition to the pain and the risk of death or disability, people experiencing these illnesses face economic consequences now rising like out-of-pocket expenditures.

Read More >
September 2018

IVAC’s VoICE tool now has over 200 data summaries and arguments to support the broad value of vaccines

VoICE, the Value of Immunization Compendium of Evidence, an online tool, aims to equip global advocates and partners with new arguments and evidence to demonstrate and support the continued investments in immunization programs, and why it is essential. This searchable online resource details the many far-reaching impacts of immunization and vaccine-preventable disease and on equity, […]

Read More >
August 2018

Press Release: Rotavirus vaccine cuts infant diarrhea deaths by a third in Malawi

A major new study has shown that rotavirus vaccination reduced infant diarrhea deaths by one-third in rural Malawi, a region with high levels of child deaths. The study led by scientists at the University of Liverpool, UCL, the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health and partners in Malawi provides […]

Read More >
July 2018

New Research: Using pneumococcal and rotavirus surveillance in vaccine decision-making: A series of case studies in Bangladesh, Armenia and the Gambia

Through a series of country case studies, this paper reviews the successful use of surveillance data for disease caused by pneumococcus and rotavirus in informing national vaccine policy in Bangladesh, Armenia and The Gambia. The case studies delve into ways in which countries are leveraging and building capacity in existing surveillance infrastructure to monitor other diseases of concern in the country.

Read More >